Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
DFN-15 in episodic migraine
NCT03006276Phase 3Completed
- Sponsor
- BioDelivery Sciences International
- Start
- Dec 2016
- Primary completion
- Nov 2017
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 3 trial of celecoxib in migraine, sponsored by BioDelivery Sciences International. Started Dec 2016; status: completed.
02
Drugs
celecoxib
03
Conditions
migraine
Beyond the preview
Go deeper on NCT03006276.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03006276.